List of Excipients in API doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg
Detailed excipient profiles for doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg
Excipient focus: AMMONIA
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants containing AMMONIA
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants containing BUTYL ALCOHOL
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants containing CELLULOSE, MICROCRYSTALLINE
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants containing CROSCARMELLOSE SODIUM
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants containing FERROSOFERRIC OXIDE
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants containing HYPROMELLOSE
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants containing ISOPROPYL ALCOHOL
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants containing MAGNESIUM STEARATE
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM TRISILICATE
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants containing MAGNESIUM TRISILICATE
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants not containing MAGNESIUM TRISILICATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg | 49884-186 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg | 49884-186 |
| >Company | >Ingredient | >NDC |
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Excipient focus: POLYETHYLENE GLYCOL
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants containing POLYETHYLENE GLYCOL
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants containing POLYSORBATE 80
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants containing PROPYLENE GLYCOL
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants containing SHELLAC
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants containing SILICON DIOXIDE
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BICARBONATE
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants containing SODIUM BICARBONATE
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants not containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants containing SODIUM LAURYL SULFATE
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants containing TALC
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants containing TITANIUM DIOXIDE
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants containing TRIETHYL CITRATE
doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
